Out of the Blue: An AJRCCM Podcast

Dr. John Fleetham chats with Dr. Barbara Jones about her ATS guideline, " Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. "

Dr. Mohleen Kang speaks with Dr. Chris Ryerson, Dr. Johannson, and Dr. Fernández Pérez about their papers, " Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography " and " Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia. "

Dr. John Fleetham speaks with Dr. Leonardo Martinez about his article, " The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis ."

Dr. Michael Lanspa chats with Dr. Ewan Goligher about his article, " Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3) ."

Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, " Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease. "

Dr. John Fleetham chats with Dr. Sonal Munsiff and Dr. Raquel Duarte about their article, " Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline ." 

Dr. John Fleetham chats with Danny Eckert about his article, " Obstructive Sleep Apnea is Exacerbated on Weekends."

Dr. Mohleen Kang chats with Dr. Stephen Humphries, Dr. Matthew Koslow, Dr. Justin Oldham, Dr. Jennifer Wang, Alexander Bankier, and Dr. David Baraghoshi about their articles, " A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis " and " One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease. "

Dr. Michael Lanspa chats with Dr. Natasha Spottiswoode and Chaz Langelier about their article, " Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis ."

Dr. John Fleetham chats with Dr. Barbro N Melgert and Dr. Chris Carlsten about their articles, " Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation " and " Inhaled Microplastics and Airway Development: Concerning Evidence from Organoid s."

Dr Michael Lanspa chats with Dr. Imeen van der Wal and Dr. Chloe Grim on their article, " Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial ." 

Dr. John Fleetham chats with Dr. Barbara Jones about her ATS guideline, " Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. "

In this podcast, we review a comparison of outcomes in patients 65-74 years old from SEER-Medicare and NLST datasets in stage I lung cancer with study first author, Dr. Nichole Tanner as well as Dr. Neal Navani.

Dr. Mohleen Kang chats with Dr. Chris Ryerson, Dr. Johannson, and Dr. Fernández Pérez about their papers, " Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography " and " Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia. "

Dr. Michael Lanspa chats with Dr. Ewan Goligher about his article, " Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3) ."

Dr. Mohleen Kang chats with Dr. Justin Oldham, Dr. Chad Newton and Dr. Jesse Roman about their papers, " Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis " and " Progress in Progressive Pulmonary Fibrosis ."

Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, " A New Global Definition of Acute Respiratory Distress Syndrome ."

Dr. John Fleetham chats with Dr. Chris Ryerson and Dr. Yet Khor about their article, " Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease ."

Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, " Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease. "

Dr. Mohleen Kang chats with Dr. Anna Podolanczuk and Dr. Gary Hunninghake about their article, " Approach to the Evaluation and Management of Interstitial Lung Abnormalities ."

Dr. John Fleetham chats with Dr. Jaclyn Smith and Dr. Imran Satia about their articles, " Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE) " and " Camlipixant: A New Hope for Refractory Chronic Cough? "

This episode originally aired on March 23rd, 2023. Dr. Michael Lanspa chats with Dr. Yahya Shehabi about his article, " Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III) ."

Dr. Michael Lanspa chats with Dr. Carmen Reep and Dr. Leo Heunks about their article, " Early vs. Delayed Switching from Controlled to Assisted Ventilation: A Target Trial Emulation ."

This episode originally aired on January 17th, 2024. Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, " A New Global Definition of Acute Respiratory Distress Syndrome ."

Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, " Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease. "